Product Info Chap 1

Question 1

Fill in the blanks. ELITEK® is indicated for the initial management of plasma uric acid levels in pediatric and adult patients with ________, ___________, and __________ who are receiving anti-cancer therapy expected to result in tumor lysis and subsequent elevation of plasma uric acid.

Answer 1

leukemia; lymphoma; solid tumor malignancies

Question 2

ELITEK® is available in what dosage form?
A. Capsule 
B. Granules 
C. Liquid 
D. Powder

Answer 2

D. Powder

Question 3

True or false. If the first round of ELITEK® treatment is insufficient to reduce uric acid levels, a second round may be given one week following the last dose.
____ True ____ False

Answer 3

False

Question 4

Rasburicase catalyzes oxidation of the poorly soluble uric acid into what metabolite?
A. Allantoin
B. Hypoxanthine 
C. Purine
D. Xanthine

Answer 4

A. Allantoin

Question 5

True or false. The recommended dose of ELITEK® is 0.2mg/kg as a 30- minute intravenous infusion daily for up to 5 days.
____ True ____ False

Answer 5

True